Upstream Bio Inc

NEW
NAS:UPB (USA)  
$ 8.41 +0.88 (+11.8%) 10:08 PM EST
At Loss
Market Cap:
$ 450.75M
Enterprise V:
$ 181.11M
Volume:
211.49K
Avg Vol (2M):
254.91K
Trade In:
Volume:
211.49K
At Loss
Avg Vol (2M):
254.91K

Business Description

Description
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 113.68
Equity-to-Asset -0.69
Debt-to-Equity -0.01
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.31
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 63.57
9-Day RSI 52.2
14-Day RSI 44.14
3-1 Month Momentum % -61.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 20.9
Quick Ratio 20.9
Cash Ratio 20.29
Days Sales Outstanding 139.85

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -3143.14
Net Margin % -2632.45
FCF Margin % -3601.7
ROA % -14.04
ROIC % -691.81
ROC (Joel Greenblatt) % -2927.14
ROCE % -17.59

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 342.75
EV-to-EBIT -5.45
EV-to-EBITDA -5.46
EV-to-Revenue 171.35
EV-to-Forward-Revenue 60.37
EV-to-FCF -4.76
Earnings Yield (Greenblatt) % -18.35
FCF Yield % -8.52

Financials

UPB's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:UPB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Upstream Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.057
EPS (TTM) ($) -0.823
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 44.14
14-Day ATR ($) 0.989975
20-Day SMA ($) 7.9305
12-1 Month Momentum % -
52-Week Range ($) 6.65 - 29.4599
Shares Outstanding (Mil) 53.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Upstream Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Upstream Bio Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Upstream Bio Inc Frequently Asked Questions

What is Upstream Bio Inc(UPB)'s stock price today?
The current price of UPB is $8.41. The 52 week high of UPB is $29.46 and 52 week low is $6.65.
When is next earnings date of Upstream Bio Inc(UPB)?
The next earnings date of Upstream Bio Inc(UPB) is .
Does Upstream Bio Inc(UPB) pay dividends? If so, how much?
Upstream Bio Inc(UPB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1